MD Conference Express EASD 2012 - (Page Cover3)

Save The DaTe! JUNE 21-25, 2013 CHICAGO You Won’t Want to Miss... • Cutting-edge clinical research • Presentations by world renowned diabetes experts • ver 2,000 oral and poster O presentations • he opportunity to earn up to T 33 Continuing Education Credits • Meet-the-Expert Sessions • Guided Audio Poster Tours ...and much more! iMPoRtant DatEs to REMEMBER... • Abstract Submission opens October 1, 2012 • Registration and Housing open early December 2012 • Abstract Submission deadline will be January 7, 2013 SEE YOU IN CHICAGO! scientificsessions.diabetes.org  http://scientificsessions.diabetes.org http://scientificsessions.diabetes.org

Table of Contents for the Digital Edition of MD Conference Express EASD 2012

MD Conference Express EASD 2012
Contents
Understanding Incretin Hormone Action and the Treatment of Diabetes
New ADA/EASD Guidelines Focus on Patient-Centered Care
ORIGIN Trial: Insulin Glargine and n-3 Fatty Acids Fail to Reduce CV Events in Diabetic Patients
Exenatide Once Weekly Sustained Improvement in Glycemic Control with Weight Loss Through 4 Years
DiaPep277® Shows Promise as a Therapeutic Strategy for T1DM
Linagliptin Proves Safe and Effective as Add-on Therapy to Basal Insulin
12-Week Treatment with LY2409021 Significantly Lowers HbA1C and Is Well Tolerated in Patients with T2DM
Insulin Degludec Is Superior to Sitagliptin in Improving Glycemic Control in Uncontrolled Patients with Type 2 Diabetes on Oral Agents
Dapagliflozin Does Not Impact Renal Function in Patients with T2DM
Population-Based Screening for T2DM:The ADDITION-Cambridge Trial
The Challenges of Pharmaceutical Management of Painful Diabetic Peripheral Neuropathy
Enterovirus Infection
Novel Oral Agents
GLP-1
Genetics
Renal Denervation
Hypertension and Renal Function Are Risk Factors for CAD in T1DM

MD Conference Express EASD 2012

https://www.nxtbook.com/nxtbooks/md_conference_express/easd2012
https://www.nxtbookmedia.com